CENTA CENTRAL GARDEN & PET CO
Wholesale-Miscellaneous Nondurable Goods · Nasdaq · SEC CIK 887733 · Fiscal year ends 09/27
Financial factors as of 2026-06-27 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY-1.2%
TTM net income YoY20.1%
TTM EPS YoY23.9%
Revenue 3-yr CAGR-1.9%
Net income 3-yr CAGR11.2%
Margins
Gross margin32.5%
Operating margin8.1%
Net margin5.4%
FCF margin11.2%
EBITDA margin10.8%
Returns
ROE10.0%
ROA4.5%
ROIC (approx.)9.5%
Asset turnover0.83x
Leverage & solvency
Liabilities / assets53.9%
Debt / equity0.68x
Current ratio3.79x
Interest coverage4.37x
Cash quality & payout
Operating cash flow / net income2.35x
Accruals ratio-6.0%
Payout ratio—
Capex / revenue1.4%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-09-27 | FY20242024-09-28 |
|---|---|---|
| Income statement | ||
| Revenue | $3.13B | $3.20B |
| Cost of revenue | $2.13B | $2.26B |
| Gross profit | $997.34M | $943.74M |
| SG&A expense | $747.29M | $758.35M |
| Operating income | $250.04M | $185.39M |
| Interest expense | $57.70M | $57.53M |
| Pretax income | $216.75M | $142.43M |
| Income tax | $52.79M | $33.11M |
| Net income | $162.84M | $107.98M |
| EBITDA | $334.94M | $276.19M |
| EPS (basic) | 2.58 | 1.64 |
| EPS (diluted) | 2.55 | 1.62 |
| Weighted avg. shares (diluted) | 63.81M | 66.86M |
| Balance sheet | ||
| Cash & equivalents | $882.49M | $768.40M |
| Receivables | $325.30M | $326.22M |
| Inventory | $722.11M | $757.94M |
| Current assets | $1.98B | $1.89B |
| PP&E, net | $363.19M | $379.17M |
| Goodwill | $554.69M | $551.36M |
| Intangibles | $447.64M | $473.28M |
| Total assets | $3.63B | $3.55B |
| Current liabilities | $538.76M | $515.38M |
| Short-term debt | $62,000 | $239,000 |
| Long-term debt | $1.19B | $1.19B |
| Total debt | $1.19B | $1.19B |
| Total liabilities | $2.04B | $2.00B |
| Shareholders' equity | $1.58B | $1.56B |
| Net debt | $309.21M | $421.64M |
| Cash flow statement | ||
| Operating cash flow | $332.51M | $394.89M |
| Capital expenditure | $41.42M | $43.13M |
| Free cash flow | $291.09M | $351.76M |
| Investing cash flow | -$44.89M | -$105.19M |
| Financing cash flow | -$156.64M | -$25.44M |
| Depreciation & amortization | $84.89M | $90.81M |
| Stock-based compensation | $21.06M | $20.58M |
| Share buybacks | $155.07M | $24.07M |
Free plan shows the latest 2 periods; Pro shows all 17 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.